Vignesh Rajah, SVP & CMO at Y-mAbs Therapeutics, Inc. (YMAB), bought 1,195 shares at $4.92 ($6K) on 2022-11-15, disclosed to the SEC on 2022-11-16.
Open-market purchase of $6k YMAB by SVP & CMO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| YMAB | BUY | 2020-12-04 | $146K | — | Filing → |